Robin Farmanfarmaian

Robin Farmanfarmaian, a distinguished professional speaker and entrepreneur, is at the vanguard of healthcare and biotechnology innovation. She has played a pivotal role in over 20 early-stage startups, co-founding 5, including the notable Organ Preservation Alliance. Her work with the Alliance, which involved collaborations with the White House and DoD, focused on advancing cryopreservation and tissue engineering for organ transplants.

Currently, Robin is the co-founder of Face Touch Aware, an Apple Watch app designed to mitigate COVID-19 transmission by reducing face-touching habits. She is also an advisor to several cutting-edge companies, such as MindMaze, a BCI and VR neuro company with FDA and CE Mark clearance, and X-Therma, a cryopreservation company for cell therapies and organ transplants. Her investment portfolio includes Invicta Medical, Rational Vaccines, and Aerami Therapeutics, showcasing her commitment to transformative healthcare solutions.

As a prolific speaker, Robin has delivered over 200 presentations across 15 countries, sharing her insights on the intersection of technology and healthcare. Her expertise in driving healthcare innovation is further evidenced by her authorship of four books, including “The Patient as CEO: How Technology Empowers the Healthcare Consumer” and the recent “How AI Can Democratize Healthcare: The Rise in Digital Care.”

In addition to her entrepreneurial endeavors, Robin serves as an advisor to multiple healthcare companies, including Luxsonic Technologies, Alacrity Care, iSono, and ConceptVines. She is also involved with ARPA-H's advisory council, helping to direct $1.5 billion towards groundbreaking healthcare technologies. Robin Farmanfarmaian's career is a testament to her profound impact on healthcare innovation, leveraging technology to enhance patient care and medical research.